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OBJECTIVES We sought to evaluate and validate the ability of the angiographic myocardial blush grade to
risk stratify patients after successful angioplasty in acute myocardial infarction (AMI).
BACKGROUND Although epicardial Thrombolysis In Myocardial Infarction (TIMI)-3 flow is restored in
90% of patients undergoing primary percutaneous coronary intervention (PCI), normal
myocardial perfusion may be present less frequently and may detrimentally impact survival.
METHODS A cohort of 173 consecutive patients undergoing intervention within 24 h of AMI onset were
studied. High-risk features of this population included failed thrombolysis in 39%, cardio-
genic shock in 17% and saphenous vein graft culprit in 11% of patients.
RESULTS Despite the restoration of TIMI-3 flow in 163 (94.2%) patients, myocardial perfusion, as
evidenced by normal contrast opacification of the myocardial bed subtended by the infarct
artery (myocardial blush), was normal in only 29.4% of patients with TIMI-3 flow following
PCI, and in no patient with TIMI 0 to 2 flow. In patients in whom TIMI-3 flow was
restored, survival was strongly dependent on the myocardial perfusion grade; one-year
cumulative mortality was 6.8% with normal myocardial blush, 13.2% with reduced myocardial
blush and 18.3% in patients with absent myocardial blush (p  0.004).
CONCLUSIONS Abnormal myocardial perfusion is present in most patients following primary or rescue PCI
in AMI, despite restoration of brisk epicardial coronary flow. In high risk patients achieving
TIMI-3 flow after intervention, the myocardial blush score may be used to stratify prognosis
into excellent, intermediate and poor survival. Further study is warranted to examine whether
adjunctive mechanical or pharmacologic strategies can further improve myocardial perfusion
and survival of patients with acute myocardial infarction undergoing intervention. (J Am
Coll Cardiol 2002;39:591–7) © 2002 by the American College of Cardiology
Brisk epicardial coronary (Thrombolysis In Myocardial
Infarction [TIMI]-3) flow is restored in 90% of patients
with acute myocardial infarction (AMI) undergoing primary
angioplasty at skilled centers (1,2). Despite this high rate of
patency, myocardial recovery is often suboptimal, and mor-
tality—especially in high-risk patients, such as those with
anterior myocardial infarction and cardiogenic shock—is
still considerable (3–5). Recent studies with myocardial
contrast echocardiography (6), positron emission tomogra-
phy (7) and sophisticated nuclear imaging techniques (8)
have clearly demonstrated that myocardial perfusion and
metabolism is often abnormal, despite restoration of
TIMI-3 flow. This has prompted the search for a simple,
reproducible means to assess myocardial microcirculation.
In 1998, van’t Hof et al. (9), from Zwolle, the Nether-
lands, described the concept of myocardial blush, the
contrast opacification of the myocardial bed subtended by
the infarct artery, and found that the degree of myocardial
perfusion so assessed correlated with survival after primary
percutaneous coronary intervention (PCI) (9). An advan-
tage of this method is the potential for simple “on-line”
determination of myocardial perfusion immediately after
angioplasty in the catheterization laboratory, while still in
the therapeutic window during which measures may be
taken to improve a suboptimal result. However, the Zwolle
method has not been validated at other centers, and the
predictors of normal myocardial blush and the impact of
normalized myocardial perfusion in a nonselected high-risk
referral population with AMI after successful PCI remains
incompletely characterized. We therefore examined the
acute and late impact of myocardial blush grade in a high
risk AMI cohort undergoing mechanical reperfusion ther-
apy at a tertiary referral center.
METHODS
Patient population. Consecutive patients at the Washing-
ton Cardiology Center undergoing percutaneous interven-
tion within 24 h of symptom onset of AMI with ST
segment elevation or left bundle branch block from January
1995 through April 1999 were identified. All patients were
considered, regardless of age, hemodynamic status, infarct
vessel and whether thrombolytic therapy had been given
prior to the intervention. Of 191 such patients, angio-
graphic films were available and technically adequate for
quantitative coronary analysis in 173 (91%). All patients
provided informed written consent for longitudinal data
collection and reporting.
Data collection and methodology. In-hospital clinical
data were collected prospectively on site by dedicated
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research nurses. Follow-up was conducted using physician
office visits and study nurse interview by a separate group of
research associates. All adverse events were adjudicated by
an independent adjudication committee at the Cardiovas-
cular Research Foundation after review of original source
documentation. Qualitative and quantitative angiographic
core laboratory analyses were performed as previously de-
scribed by technicians blinded to clinical outcomes (10).
Antegrade blood flow in the infarct vessel was evaluated
using the TIMI scale (11). All films were over-read for
accuracy by a physician (A. J. L.).
Myocardial blush was graded densitometrically based on
visual assessment of relative contrast opacification of the
myocardial territory subtended by the infarct vessel in
relation to epicardial density as described by van’t Hof et al.
(9). Blush score 0  absence of contrast opacification in the
myocardial infarct zone or persistent stain without washout;
blush 1  minimal contrast opacification; blush 2 
reduced but clearly evident blush in the infarct zone com-
pared to the ipsilateral or contralateral noninvolved epicar-
dial vessel(s); and blush 3myocardial contrast filling equal
to or greater than that seen in the noninvolved epicardial
vessel(s). From multiple orthogonal projections, the single
view was chosen that best isolated the myocardial infarct
zone in question, most commonly the right anterior oblique
(RAO) projection with cranial angulation for the left
anterior descending artery (LAD) distribution, the RAO
caudal or left lateral projection for the left circumflex artery
(LCX), and either the left anterior oblique or RAO projec-
tions for the right coronary artery (RCA) distribution. For
this analysis, blush grades were scored by two physicians not
involved in the TIMI flow analysis (M. A. P. and G. W. S.).
Inter- and intraobserver variability were determined from a
random sample of 40 films scored by both reviewers (Table 1).
Statistical analysis. Categorical variables were compared
by chi-square analysis or Fisher’s exact test. Continuous
variables are presented as mean  standard deviation and
were compared by Student t test, Mann-Whitney U test, or
ANOVA, as appropriate. All p values are two-tailed.
Follow-up clinical events were analyzed with actuarial
methods and Kaplan-Meier curves were constructed. The
influence of baseline demographic and angiographic vari-
ables on mortality during the follow-up period was evalu-
ated with the log rank test. Cox proportional hazard
regression was used to determine the independent predic-
tors of late adverse events. For all analyses, significance was
determined at the p  0.05 level.
RESULTS
Patient population and baseline characteristics. The
study cohort at this tertiary referral center consisted of a
high-risk group of patients (Table 2), with 29 (16.8%)
presenting in cardiogenic shock, 68 patients (39.3%) under-
going rescue angioplasty for failed thrombolysis and 19
Abbreviations and Acronyms
AMI  acute myocardial infarction
CABG  coronary artery prior bypass grafting
CPK-MB  creatine phosphokinase-MB isozyme
LAD  left anterior descending artery
LCX  left circumflex artery
PCI  percutaneous coronary intervention
RAO  right anterior oblique
RCA  right coronary artery
TIMI  Thrombolysis In Myocardial Infarction
Table 1. Inter- and Intraobserver Variability of Myocardial Blush Grades
N Agreement
Difference
1 Grade 2 Grades 3 Grades
Intraobserver variability 40 37 (92.5%) 3 (7.5%) 0 (0%) 0 (0%)
Interobserver variability 40 34 (85.0%) 5 (12.5%) 1 (2.5%) 0 (0%)
Table 2. Baseline Characteristics in 173 Patients
Clinical Feature N (%)
Age (yrs) 61  13
Female 49 (28.3%)
Hypertension 104 (60.1%)
Diabetes 42 (24.3%)
Hypercholesterolemia 97 (56.1%)
Current cigarette use 48 (27.8%)
Prior MI 67 (38.7%)
Prior PCI 46 (26.6%)
Prior bypass surgery 29 (16.8%)
Chronic renal insufficiency 15 (8.7%)
Hemodialysis dependent 3 (1.7%)
Chest pain to hospital (min) 242  188
Chest pain to angiography (min) 333  201
Left ventricular ejection fraction (n  91) 38%  11%
Angiographic Characteristics (core lab)
Myocardial infarct territory
Left anterior descending artery 80 (46.2%)
Left circumflex artery 31 (18.1%)
Right coronary artery 62 (35.7%)
Infarct vessel
Native coronary artery 154 (89.0%)
Saphenous vein graft 19 (11.0%)
Baseline TIMI flow
0/1 86 (49.7%)
2 26 (15.1%)
3 61 (35.2%)
Reference vessel diameter (mm) 2.81  0.62
Minimal luminal diameter (mm) 0.50  0.61
Baseline diameter stenosis 81%  21%
Lesion length (mm; n  88) 13.6  7.9
MI  myocardial infarction; PCI  percutaneous coronary intervention; TIMI 
Thrombolysis In Myocardial Infarction.
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patients (11.0%) having an occluded saphenous vein graft as
the infarct-related artery. An intra-aortic balloon pump was
required in 76 (43.9%) patients, including placement in
11.0% of patients prior to arrival in the catheterization
laboratory for sustained hypotension.
Procedural results and late outcomes. Balloon angio-
plasty was performed in all patients; stents were implanted
in 103 patients (59.5%), and thrombectomy or thrombo-
ablative devices (atherectomy, laser) were used in 20 patients
(11.6%). Glycoprotein IIb/IIIa receptor antagonists were
administered in 32 (18.5%) of patients, mostly for subopti-
mal results. A mean of 1.5  0.8 lesions were treated per
patient. The final minimal luminal diameter was 2.55 
0.69 mm, and the residual stenosis was 12  32%. By core
laboratory angiographic analysis, TIMI-3 flow was restored
in 163 patients (94.2%).
In-hospital adverse events included death in 14 patients
(8.1%), reinfarction in 1 patient (0.6%) and target vessel
revascularization in 12 patients (6.9%). The mean follow-up
duration was 1.5 1.4 years. By actuarial analysis, 13.7% of
patients had died at one year, and 4.0% had developed
reinfarction. By Cox proportional hazards regression, inde-
pendent determinants of mortality were advanced age,
cardiogenic shock on admission, LAD intervention and
inability to restore TIMI-3 flow (Table 3).
Myocardial perfusion status, infarct size and effect on
outcomes. As seen in Figure 1, normal myocardial perfu-
sion prior to intervention as evidenced by a blush score of 3
was significantly less likely to be present than was normal
epicardial TIMI-3 flow (9.3% vs. 35.2%, p  0.0001);
normal blush was present in 0% of patients with TIMI 0-2
flow at baseline, versus 20.5% of patients with initial
TIMI-3 flow (p  0.0001). Similarly, normal blush after
angioplasty was present in only 48 patients (27.9%), despite
the fact that TIMI-3 flow was restored in 163 patients
(94.2%) (p 0.0001, Fig. 1). Normal blush was not present
in any patient with TIMI 0-2 flow after intervention,
compared with 29.4% of patients with TIMI-3 flow after
angioplasty (p  0.04).
In addition to TIMI flow, the only other significant
baseline correlate of restoration of normal myocardial blush
was the coronary vessel undergoing intervention (Table 4).
A blush score of 3 was achieved in 15.0% of patients
undergoing intervention in the LAD myocardial territory,
in 25.8% of patients undergoing intervention in the LCX
distribution and in 45.2% of patients undergoing interven-
tion in the RCA distribution (p  0.0003). In this series,
procedural stent implantation was also positively associated
with achievement of normal blush, whereas there was no
relationship with procedural glycoprotein IIb/IIIa inhibitor
use (Table 4).
The degree of angiographic myocardial perfusion after
intervention correlated with infarct size as estimated by peak
creatine phosphokinase-MB isozyme (CPK-MB) in all
patients, as well as in the subset of 163 patients in whom
TIMI-3 flow was restored (Fig. 2). Abnormal postproce-
Table 3. Univariate and Multivariate Predictors of Cumulative Mortality
1 Year Mortality
Univariate
p Value
Multivariate
OR (95% CI)
Multivariate
p Value
Variable
Present
Variable
Absent
Cardiogenic shock 41.4% 7.6% 0.0001 9.9 (4.1, 23.8) 0.0001
Final TIMI 3 40.0% 11.7% 0.01 5.2 (1.6, 16.6) 0.005
Age 70 years 27.5% 7.4% 0.004 4.3 (1.8, 10.1) 0.001
LAD intervention 18.9% 9.1% 0.06 2.5 (1.1, 6.4) 0.047
LAD  left anterior descending artery; OR (95% CI)  odds ratio (95% confidence interval bounds); TIMI  Thrombolysis
In Myocardial Infarction.
Figure 1. Rates of Thrombolysis In Myocardial Infarction (TIMI) flow grades and myocardial blush scores by separate core laboratory analysis before (left)
and after (right) procedure.
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dure myocardial blush also correlated with in-hospital and
cumulative mortality, though not as strongly in this regard
as did reduced postintervention epicardial TIMI flow (Fig.
3). However, in patients in whom TIMI-3 flow was
restored, the degree of restored myocardial perfusion
strongly correlated with early and late survival (Fig. 4); this
relationship held in both patients with anterior and nonan-
terior infarction (Fig. 5, left), and was especially strong in
patients with cardiogenic shock (Fig. 5, right). There were
no differences in cumulative rates of reinfarction as a
function of myocardial perfusion in patients with TIMI-3
flow; reinfarction occurred in 4.2% of patients with final
blush score 3, 2.8% of patients with blush score 2 and 2.3%
of patients with blush score 0/1 (p  0.87).
DISCUSSION
The present study demonstrates that despite restoration of
brisk antegrade epicardial blood flow by mechanical reper-
fusion therapy in a broad cross section of patients with
evolving AMI, angiographic evidence of normal myocardial
perfusion is achieved in only a minority of patients. Fur-
thermore, the simple assessment of the degree of myocardial
contrast opacification immediately after percutaneous inter-
vention allows prognostic stratification of patients with
TIMI-3 flow into three well circumscribed strata of survival,
with an approximate threefold difference in mortality.
Correlates and impact of normal myocardial blush. The
strongest predictors of not achieving normal myocardial
blush were the inability to achieve TIMI-3 flow and
angioplasty in the LAD territory. Although it is intuitive
that myocardial perfusion is likely to be suboptimal if
epicardial flow is depressed, the reason that LAD interven-
tion is less likely to result in normal myocardial perfusion is
less obvious and may relate to increased thrombus burden
and atheroembolism, more active vasohumoral responses or
greater myocardial edema and necrosis in LAD infarction
(12–14). Regardless of the cause, it is interesting to specu-
late whether the greater mortality of patients with anterior
myocardial infarction compared with nonanterior myocar-
dial infarction is due not only to the increased muscle mass
Table 4. Correlates of Normal Myocardial Blush Following Intervention
Clinical Feature
Final Blush  3
(n  48)
Final Blush  0 to 2
(n  125) p Value
Age (yrs) 59.7  11.6 62.1  13.8 0.30
Female gender 14 (29.2%) 35 (28.0%) 0.88
Hypertension 31 (64.6%) 73 (58.4%) 0.46
Diabetes mellitus 12 (25.0%) 30 (24.0%) 0.89
Hypercholesterolemia 25 (52.1%) 72 (57.6%) 0.52
Current cigarette use 16 (33.3%) 32 (25.6%) 0.31
Prior MI 20 (41.7%) 47 (37.6%) 0.62
Prior CI 12 (25.0%) 34 (27.2%) 0.77
Prior bypass surgery 8 (16.7%) 21 (16.8%) 0.98
Chronic renal insufficiency 2 (4.2%) 13 (10.4%) 0.19
Chest pain to hospital (min) 226  160 265  199 0.58
Chest pain to angiography (min) 314  184 359  216 0.67
Cardiogenic shock on admission 5 (10.4%) 24 (19.2%) 0.17
Primary PCI without prior lytics 27 (56.3%) 78 (62.4%) 0.45
Rescue PCI for failed thrombolysis 21 (43.8%) 47 (33.6%) 0.45
Baseline LVEF (n  91) 40%  12% 38%  12% 0.38
Angiographic Characteristics (Core Lab)
Myocardial infarct territory
Left anterior descending 12 (25.0%) 68 (54.4%) 0.003
Left circumflex 8 (16.7%) 23 (18.4%) 0.97
Right 28 (58.3%) 34 (27.2%) 0.0001
Infarct vessel
Native coronary artery 44 (91.7%) 110 (88.0%) 0.49
Saphenous vein graft 4 (8.3%) 15 (12.0%) 0.49
Reference vessel diameter (mm) 2.91  0.54 2.78  0.65 0.15
Minimal luminal diameter (mm) 0.62  0.62 0.47  0.59 0.13
Baseline diameter stenosis 78%  19 82%  21 0.34
Lesion length (mm; n  88) 14.4  9.9 13.2  6.9 0.53
Procedural Device and Drug Use
Stent implantation 35 (72.9%) 68 (54.4%) 0.03
Atheroablation 5 (10.4%) 15 (12.0%) 0.77
Balloon angioplasty only 14 (29.2%) 61 (48.8%) 0.02
Glycoprotein IIb/IIIa inhibitors 9 (18.8%) 23 (18.4%) 0.96
CI  confidence interval; LVEF  left ventricular ejection fraction; MI  myocardial infarction; PCI  percutaneous coronary
intervention.
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at risk (15), but also to a lower likelihood of achieving
normal myocardial perfusion despite restored epicardial
flow.
In addition to validating the reproducibility and utility of
the Zwolle method, these data complement and extend the
prior findings of van’t Hof et al. (9) in several important
ways. The current patient population, in whom both pri-
mary and rescue PCI was performed for failed thrombolysis
and who were characterized by a high prevalence of cardio-
genic shock, was at significantly higher risk of mortality
(14% 1-year mortality) and less selected than the pure
primary PCI cohort in the prior study (9). Furthermore, as
seen in Figure 3, absent epicardial flow (TIMI 0/1) was
found to be the strongest angiographic predictor of mortal-
ity after PCI in AMI, whereas the achievement of normal
myocardial perfusion as assessed by blush was a more
powerful predictor of survival than attaining TIMI-3 flow.
Moreover, in patients achieving normal epicardial perfusion
(TIMI-3 flow), the degree of myocardial perfusion restored
was strongly associated with infarct size and subsequent
early and late survival. The observation that normal myo-
cardial blush was achieved in only 28% of patients in this
series (despite 94% TIMI-3 flow) and in only 19% of
patients in the Zwolle population (9), is strong evidence that
most patients are not achieving an optimal result after
mechanical reperfusion therapy. Further investigation is
required to determine whether adjunctive therapies can be
identified, which, if applied before or after angioplasty in
evolving AMI, are able to facilitate restoration of normal
myocardial perfusion in a greater percentage of patients, and
whether such interventions translate into improved myocar-
dial salvage and enhanced survival. In this regard, both
glycoprotein IIb/IIIa inhibitors (16) and devices to protect
the distal microcirculation from atheroembolic and throm-
botic debris (14) have shown early promise.
Of note, the beneficial effect on survival of restoring
Figure 2. Infarct size as estimated by peak serum creatine phosphokinase-MB isozyme (CPK-MB) levels after intervention, stratified by myocardial blush
score, in all 173 patients (left) and in 163 patients in whom Thrombolysis In Myocardial Infarction (TIMI)-3 flow was also restored (right).
Figure 3. Cumulative survival (including in-hospital and late events) after percutaneous intervention in 173 patients with acute myocardial infarction,
stratified by final procedural Thrombolysis In Myocardial Infarction (TIMI) flow (left) and myocardial blush score (right). P values represent log rank for
trend.
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normal myocardial perfusion was most evident in patients
with the most myocardium at risk, that is, those with
cardiogenic shock and LAD infarction. This finding sug-
gests that efforts to restore normal myocardial perfusion may
be most critical in patients with extensive infarction, though
advantageous trends were also seen for patients with smaller
amounts of myocardium at risk, those without shock and
with non-LAD occlusion.
Myocardial blush methodologies. The myocardial blush
scale used in the present study was adapted from the original
description of van’t Hof et al. (9) and relies on simple visual
assessment of contrast opacification in the affected myocar-
dial bed, relative to nonaffected myocardial territories. This
method has now been validated in both labs to have high
intra- and interobserver reproducibility and has also been
demonstrated to be of prognostic import in a broad variety
of patients undergoing angioplasty in AMI, including pri-
mary and rescue PCI and cardiogenic shock. In contrast,
Gibson et al. (17) have proposed an alternative, automated,
computer-enhanced videodensitometric technique of mea-
suring myocardial blush, which relies heavily on washout
rates, as well as opacification. The prognostic utility of this
instrument has been examined in an AMI population
receiving thrombolytic therapy without intervention in the
TIMI 10B study (17), but not after primary angioplasty, and
the intra- and interobserver variability of this method has
not yet been described. Whether the two methods are
comparable and equally predictive is presently unknown.
Study limitations. Conceivably, all variables affecting
myocardial blush may not have been collected. For example,
ascertainment of baseline left ventricular ejection fraction
was incomplete, and thus the contribution of left ventricular
function to achievement of myocardial perfusion and prog-
nosis is inconclusive. Time delays to intervention are also an
important determinant of myocardial recovery and survival
(18) and theoretically may affect attainment of normal
myocardial perfusion. Nonsignificant trends were present
relating delayed time to presentation and treatment with
decreased blush, which may have reached significance in a
larger population. Despite these limitations, confidence in
the analysis presented regarding the prognostic importance
of blush may be derived from the fact that all data were
prospectively collected by independent research nurses, and
adverse events were adjudicated by separate committee.
Even the degree of myocardial blush was determined by
separate physicians than those who graded TIMI flow, with
neither group having knowledge of clinical outcomes. Sec-
ond, the greater rates of normal myocardial blush achieved
in patients receiving stents in this study may seem counter-
intuitive, given the observation in recent studies that stent
implantation in AMI may degrade TIMI-3 flow (19,20).
However, the use of stents (and IIb/IIIa inhibitors) were not
Figure 4. Cumulative survival after intervention in 163 patients in whom
Thrombolysis In Myocardial Infarction (TIMI)-3 flow was achieved,
stratified by status of myocardial perfusion.
Figure 5. Cumulative survival after intervention in 163 patients in whom Thrombolysis In Myocardial Infarction (TIMI)-3 flow was achieved, stratified
by status of myocardial perfusion, and subgrouped by myocardial infarct distribution (left) and the presence or absence of cardiogenic shock at baseline
(right).
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prespecified nor controlled in this series, and data are not
available to determine whether they were used in a primary
fashion or for bail-out after a suboptimal result. Thus,
prospective randomized studies are required to determine
the impact of these and other modalities on myocardial
perfusion. Third, higher grades of myocardial blush have
been found to correlate with ST-segment resolution
(21,22), which was not evaluated in the present study;
whether this indice or other surrogates of ischemia are
complementary or additive to the assessment of myocardial
blush is unknown. Finally, although myocardial blush offers
the potential for simple “real-time” assessment and thera-
peutic response, no studies have been done evaluating the
prospective accuracy and predictive value of blush deter-
mined in the catheterization laboratory, as compared with in
a core lab. Further investigation is also required to deter-
mine whether therapeutic measures during intervention are
able to improve suboptimal myocardial blush and subse-
quently enhance prognosis.
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